Acne:
Cannabidiol [CBD]) exerts complex anti-acne effects by normalizing 'pro-acne agents 
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/27094344   

CBD has potential as a promising therapeutic agent for the treatment of acne vulgaris 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/25061872  

ADD/ADHD:
Cannabinoids in attention-deficit/hyperactivity disorder
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/28576350 
Association between cannabinoid receptor gene and childhood attention deficit/hyperactivity disorder https://www.nature.com/articles/4001278

Alcoholism: 
CBD may have therapeutic potential in the treatment of alcoholic liver diseases associated with inflammation,
oxidative stress and steatosis 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/28935932 

ALS:
Cannabidiol: a promising drug for neurodegenerative disorders
(PubMed)https://www.ncbi.nlm.nih.gov/pubmed/19228180
Cannabis and amyotrophic lateral sclerosis

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20439484

Alzheimer's:
Cannabidiol: a promising drug for neurodegenerative disorders

(PubMed)https://www.ncbi.nlm.nih.gov/pubmed/19228180
The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/22448595
CBD blunts beta-amyloid induced neuroinflammation
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+in+vivo+blunts+beta-amyloid+induced+neuroinflammation

Anxiety:
Cannabidiol induces rapid-acting antidepressant-like effects

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/26711860
Antidepressant-like and anxiolytic-like effects of cannabidiol
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/24923339
Cannabidiol reduces the anxiety induced by simulated public speaking
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+reduces+the+anxiety+induced+by+simulated+public+speaking+in+social+phobia+patients

Arthritis:
Cannabidiol is an oral anti-arthritic therapeutic

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/10920191
Cannabidiol reduces inflammation and pain-related behaviors in a rat model of arthritis
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/26517407

Autism:
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder

(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/30171992
Cannabis oil 80% successful in helping autistic children 

https://www.israelnationalnews.com/News/News.aspx/249591

Bipolar Disorder:
The therapeutic effects of cannabinoids in bipolar disorders

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/15888515
Cannabinoids in bipolar affective disorder
http://journals.sagepub.com/doi/abs/10.1177/0269881105051541

Bladder:
CBD, TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic
target for bladder cancer

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20546877

Brain:
The effect of cannabinoids (CBs) in promoting glial differentiation and inhibiting gliomagenesis
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/25903924  
CBD is a promising novel therapeutic agent for cancer
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/28888984

Breast:
Novel anti-tumor mechanisms of Cannabidiol in breast cancer 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/25660577  
The effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20859676

Cancer General:
Cannabidiol as potential anticancer drug
(Pub Med) https://www.ncbi.nlm.nih.gov/pubmed/22506672

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/25916739

Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/30150937

Colitis:
Cannabinoids may represent a useful therapeutic administration route for the treatment of colonic inflammation
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Topical+and+systemic+cannabidiol+improves+trinitrobenzene+sulfonic+acid+colitis+in+mice

Colon:
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/24373545
CBD, potentially beneficial for colon carcinogenesis
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Chemopreventive+effect+of+the+non-psychotropic+phytocannabinoid+cannabidiol+on+experimental+colon+cancer

Crohn's Disease:
Cannabis induces a clinical response in patients with Crohn's disease
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/23648372

Cannabis finds its way into treatment of Crohn's disease
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabis+finds+its+way+into+treatment+of+Crohn%E2%80%99s+disease

Go to top

Depression:

Antidepressant-like effects of cannabidiol
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Antidepressant-Like+and+Anxiolytic-Like+Effects+of+Cannabidiol%253A+A+Chemical+Compound+of+Cannabis+Sativa
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/23108553
Administration of CBD induces antidepressant-like effects
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/26801828
The endocannabinoid (eCB) system plays an important role in the control of mood
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/25488672

Diabetes:
Cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/27767974

Neuroprotective effects of cannabidiol in diabetes
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Neuroprotective+and+blood-retinal+barrier-preserving+effects+of+cannabidiol+in+experimental+diabetes
Cannabidiol lowers incidence of diabetes
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/16698671

Endocrine:
Endocannabinoids in endocrine and related tumors
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/?term=Endocannabinoids+in+endocrine+and+related+tumours

Epilepsy and Seizures:
Cannabidiol use in pediatric treatment-resistant epilepsy
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Report+of+a+parent+survey+of+cannabidiol-enriched+cannabis+use+in+pediatric+treatment-resistant+epilepsy

The potential use of CBD as an antiepileptic drug
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/7413719

Cannabidiol exerts anti-convulsant effects
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/22520455

Cannabidiol displays anti-epileptiform and antiseizure properties
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/

term=Cannabidiol+displays+antiepileptiform+and+antiseizure+properties+in+vitro+and+in+vivo

Fibromyalgia:
therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/18404144

Heart Disease:
CBD is cardioprotective

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Acute+administration+of+cannabidiol+in+vivo+suppresses+ischaemia-induced+cardiac+arrhythmias+and+reduces+infarct+size+when+given+at+reperfusion
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/21144973

Cannabidiol suppresses ischemia-induced cardiac arrhythmias
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20590615

Cannabidiol protects against myocardial ischemic
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol%252C+a+nonpsychoactive+Cannabis+constituent%252C+protects+against+myocardial+ischemic+reperfusion+injury

Go to top

IBS:

Cannabis for inflammatory bowel disease

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/24969296

Inflammation and Pain:
Cannabidiol, lessening the impact of inflammation on oxidative stress
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+as+an+emergent+therapeutic+strategy+for+lessening+the+impact+of+inflammation+on+oxidative+stress
Anti-inflammatory role of cannabidiol
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Anti-inflammatory+role+of+cannabidiol+and+O-1602+in+cerulein-induced+acute+pancreatitis+in+mice
Cannabinoids suppress inflammatory and neuropathic pain

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabinoids+suppress+inflammatory+and+neuropathic+pain+by+targeting+glycine+receptors

Insomnia / Sleep Disorders:
Cannabidiol may have therapeutic potential for the treatment of insomnia 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/28349316

Leukemia:
Cannabidiol-induced apoptosis (cell death) in human leukemia cells
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol-induced+apoptosis+in+human+leukemia+cells
Cannabidiol inhibits tumor growth in
leukemia

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=220

Liver Disease:
CBD represents a potential therapeutic agent for the treatment of liver fibrosis

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+causes+activated+hepatic+stellate+cell+death+through+a+mechanism+of+endoplasmic+reticulum+stress-induced+apoptosis
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Therapeutic+potential+of+cannabidiol+against+ischemia%252Freperfusion+liver+injury+in+rats
Cannabidiols role in autoimmune hepatitis  
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Role+of+myeloid-derived+suppressor+cells+in+amelioration+of+experimental+autoimmune+hepatitis+following+activation+of+TRPV1+receptors+by+cannabidiol

Lung:
Cannabidiol inhibits lung cancer cell invasion and metastasis
 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/22198381

Migraines:
Cannabinoids Therapeutic Implications in Medicine and Headache
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/26015168

The endocannabinoid system and migraine 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20353780

Mood Disorders:
Neural basis of anxiolytic effects of CBD in generalized social anxiety disorder

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20829306
Effects of cannabidiol (CBD) on regional cerebral blood flow

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/14583744
The endocannabinoid signaling system in psychiatric disease

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/25488672

Multiple Sclerosis:
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis
Cannabidiol Could Help Treat Multiple Sclerosis
https://medicalxpress.com/news/2013-10-chemicals-marijuana-ms.html
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in multiple sclerosis
https://www.ncbi.nlm.nih.gov/pubmed/23851307

Nausea:
Cannabidiol attenuates vomiting and nausea-like behavior
 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+attenuates+vomiting+and+nausea-like+behaviour
Regulation of nausea and vomiting by cannabinoids 
(
PubMed) https://www.ncbi.nlm.nih.gov/pubmed/21175589

Neurodegenerative Disorders:
Cannabidiol: A promising drug for neurodegenerative disorders? 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/19228180
Cannabidiol for neurodegenerative disorders 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+for+neurodegenerative+disorders%253A+Important+new+clinical+applications+for+this+phytocannabinoid%253F
Memory-rescuing effects of cannabidiol 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Memory-rescuing+effects+of+cannabidiol+in+an+animal+model+of+cognitive+impairment+relevant+to+neurodegenerative+disorders

Neuropathic Pain:
Cannabinoids in the management of difficult to treat pain 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/18728714
Cannabidiol inhibits paclitaxel-induced neuropathic pain without diminishing chemotherapy efficacy
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+inhibits+paclitaxel-induced+neuropathic+pain+without+diminishing+chemotherapy+efficacy

Targeting the Endocannabinoid System for Prevention or Treatment of Chemotherapy-Induced Neuropathic Pain
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/30147813

Go to top

Opioid / Nicotine Addiction:

Cannabinoid receptors have been shown to be a promising target in medication
development for the treatment of addition

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/29967454 
Endogenous cannabinoid and opioid systems and their role in nicotine addiction 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/20017727

Pain:
The adjuvant use of cannabinoids in cancer-related pain could provide useful benefit (PubMed) https://www.ncbi.nlm.nih.gov/pubmed/23141881
Cannabidiol inhibits paclitaxel-induced neuropathic pain
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/24117398

CBD may be effective clinically for treating both nausea and vomiting produced by chemotherapy or
other therapeutic treatments
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/21175589

Prostate:
Non-THC cannabinoids inhibit prostate carcinoma growth
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/22594963

Cannabinoid receptor as a novel target for the treatment of prostate cancer
(PubMed)  https://www.ncbi.nlm.nih.gov/pubmed/15753356

Parkinson's Disease:
Prospects for cannabinoid therapies in basal ganglia disorders 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/21545415
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/15837565

PTSD:
Cannabidiol blocks long-lasting behavioral consequences of PTSD 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+blocks+long-lasting+behavioral+consequences+of+predator+threat+stress
The endocannabinoid system in anxiety, fear memory and habituation 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/21768162


Rheumatoid Arthritis:

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/
term=Cannabidiol+as+an+emergent+therapeutic+strategy+for+lessening+the+impact+of+inflammation+on+oxidative+stress
The endocannabinoid system has been proposed as modulator of RA, rheumatoid arthritis
http://norml.org/library/item/rheumatoid-arthritis


Schizophrenia and Psychosis:

Cannabidiol as a potential treatment for psychosis 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/24309088
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Cannabidiol+enhances+anandamide+signaling+and+alleviates+psychotic+symptoms+of+schizophrenia
Cannabidiol: A new light for schizophrenia? 
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Medical+use+of+cannabis.+Cannabidiol%253A+A+new+light+for+schizophrenia%253F
Cannabidiol as an antipsychotic drug
(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/16612464

Skin:
Anticancer activity of anandamide in human cutaneous melanoma cells
 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/?term=Anticancer+activity+of+anandamide+in+human+cutaneous+melanoma+cells
Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death
(Pub Med) https://www.ncbi.nlm.nih.gov/pubmed/25674907

Stress:
Attenuate the anxiogenic effects induced by Chronic Unpredictable Stress
 

(PubMed) https://www.ncbi.nlm.nih.gov/pubmed/29510186
The endocannabinoid system as a target for novel anxiolytic drugs
(Pub Med) https://www.ncbi.nlm.nih.gov/pubmed/28434588

Tourettes Syndrome:
T
herapeutic potential of cannabis in Tourette syndrome 

(PubMed) Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report.
Treatment with nabiximols resulted in major improvements of both tics and premonitory urges
(Pub Med) Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome

Go to top 






width="400"